Search research articles
Contact Us
Filters
Showing results (51-60 of 78) with videos related to
Page
of 8
Sort By:
Lung Cancer (Amsterdam, Netherlands)
|
June 20, 2020
Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors
Dan Zhao, Isa Mambetsariev, Haiqing Li, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 18, 2025
Cancer Survival at a Comprehensive Cancer Center Compared with Surveillance, Epidemiology, and End Results (SEER) Estimates
Ravi Salgia, Joseph Alvarnas, Vijay Trisal, et al.
Cancers
|
June 2, 2021
Molecular and Clinical Features of Hospital Admissions in Patients with Thoracic Malignancies on Immune Checkpoint Inhibitors
Dan Zhao, Haiqing Li, Isa Mambetsariev, et al.
Journal of Clinical Medicine
|
November 26, 2022
Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans
Linda D Bosserman, Isa Mambetsariev, Colton Ladbury, et al.
Translational Lung Cancer Research
|
June 15, 2026
Case report: durable response to osimertinib, radiotherapy, and chemotherapy combination in advanced non-small cell lung cancer with atypical metastasis
Javier Arias-Romero, Isa Mambetsariev, Jeremy Fricke, et al.
International Journal of Oncology
|
April 3, 2020
Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell lines
Tamara Mirzapoiazova, Alexander Pozhitkov, Arin Nam, et al.
Iscience
|
November 16, 2020
Activation of EPHA2-ROBO1 Heterodimer by SLIT2 Attenuates Non-canonical Signaling and Proliferation in Squamous Cell Carcinomas
Saumya Srivastava, Ka Ming Pang, Mari Iida, et al.
Frontiers in Oncology
|
March 2, 2023
Predicting survival of NSCLC patients treated with immune checkpoint inhibitors: Impact and timing of immune-related adverse events and prior tyrosine kinase inhibitor therapy
Michael R Sayer, Isa Mambetsariev, Kun-Han Lu, et al.
Translational Lung Cancer Research
|
June 15, 2026
Patterns of central nervous system disease and molecular landscape in epidermal growth factor receptor exon 20 insertion mutated non-small cell carcinoma
Amanda Reyes, Isa Mambetsariev, Jeremy Fricke, et al.
Journal of Clinical Medicine
|
June 21, 2020
Complex Oncological Decision-Making Utilizing Fast-and-Frugal Trees in a Community Setting-Role of Academic and Hybrid Modeling
Ravi Salgia, Isa Mambetsariev, Tingting Tan, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 78) with videos related to
Sort By:
Page
of 8
Lung Cancer (Amsterdam, Netherlands)
|
June 20, 2020
Association of molecular characteristics with survival in advanced non-small cell lung cancer patients treated with checkpoint inhibitors
Dan Zhao, Isa Mambetsariev, Haiqing Li, et al.
Medrxiv : the Preprint Server for Health Sciences
|
September 18, 2025
Cancer Survival at a Comprehensive Cancer Center Compared with Surveillance, Epidemiology, and End Results (SEER) Estimates
Ravi Salgia, Joseph Alvarnas, Vijay Trisal, et al.
Cancers
|
June 2, 2021
Molecular and Clinical Features of Hospital Admissions in Patients with Thoracic Malignancies on Immune Checkpoint Inhibitors
Dan Zhao, Haiqing Li, Isa Mambetsariev, et al.
Journal of Clinical Medicine
|
November 26, 2022
Pyramidal Decision Support Framework Leverages Subspecialty Expertise across Enterprise to Achieve Superior Cancer Outcomes and Personalized, Precision Care Plans
Linda D Bosserman, Isa Mambetsariev, Colton Ladbury, et al.
Translational Lung Cancer Research
|
June 15, 2026
Case report: durable response to osimertinib, radiotherapy, and chemotherapy combination in advanced non-small cell lung cancer with atypical metastasis
Javier Arias-Romero, Isa Mambetsariev, Jeremy Fricke, et al.
International Journal of Oncology
|
April 3, 2020
Effects of selected deubiquitinating enzyme inhibitors on the proliferation and motility of lung cancer and mesothelioma cell lines
Tamara Mirzapoiazova, Alexander Pozhitkov, Arin Nam, et al.
Iscience
|
November 16, 2020
Activation of EPHA2-ROBO1 Heterodimer by SLIT2 Attenuates Non-canonical Signaling and Proliferation in Squamous Cell Carcinomas
Saumya Srivastava, Ka Ming Pang, Mari Iida, et al.
Frontiers in Oncology
|
March 2, 2023
Predicting survival of NSCLC patients treated with immune checkpoint inhibitors: Impact and timing of immune-related adverse events and prior tyrosine kinase inhibitor therapy
Michael R Sayer, Isa Mambetsariev, Kun-Han Lu, et al.
Translational Lung Cancer Research
|
June 15, 2026
Patterns of central nervous system disease and molecular landscape in epidermal growth factor receptor exon 20 insertion mutated non-small cell carcinoma
Amanda Reyes, Isa Mambetsariev, Jeremy Fricke, et al.
Journal of Clinical Medicine
|
June 21, 2020
Complex Oncological Decision-Making Utilizing Fast-and-Frugal Trees in a Community Setting-Role of Academic and Hybrid Modeling
Ravi Salgia, Isa Mambetsariev, Tingting Tan, et al.
Page
of 8